Back

The CNP analogue vosoritide reduces arrhythmia in diabetic cardiomyopathy via cGMP-dependent PDE2 stimulation on cellular and organ level

1 September 2024 (14:40 - 14:50)
Organised by: Logo
Congress Presentation Part of: Novel mechanisms of arrhythmogenic cardiac disease Arrhythmias ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Ms Rebecca Firneburg

Faculty of Medicine Carl Gustav Carus TU Dresden, Dresden (Germany)

5 More presentations in this session

Presentation thumbnail
Serum exosomal long non-coding RNA H19 as a theragnostic target for atrial fibrillation
Ms J. Kang (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Investigating the role of an orphan nuclear receptor NR4A1 in atrial fibrillation
Mr C. Yiu (Oxford, GB)
Abstract Slides Video
Presentation thumbnail
Role of common variants and new genes associated with arrhythmogenic cardiomyopathy
Doctor J. barc (Nantes, FR)
Abstract Slides Video
Presentation thumbnail
Characterization of knock-in zebrafish models with a novel SLC4A3 variant identified in a short QT syndrome family
Ms M. Zhu (Suita, JP)
Abstract Slides Video
Presentation thumbnail
The H222P-Lamin mutation induces heart failure via impaired mitochondrial calcium uptake in human cardiac laminopathy
Professor J. Hulot (Paris, FR)
Abstract Slides Video

Access the full session

Session thumbnail
Novel mechanisms of arrhythmogenic cardiac disease
Video

The Event

Event poster

ESC Congress 2024

1 September 2024 14:40 CET
You may be interested in
thumbnail
Congress Session
Basic and Translational Late-Breaking Science session
thumbnail
Congress Session
Novel mechanisms of arrhythmogenic cardiac disease
thumbnail
Congress Session
Molecular and immune mechanisms in cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources